The current health insurance claims settlement process in the...
Category:
Health
Latest
Poor diet linked to 14 million cases of Type 2 diabetes globally: Study
Of the 30 most populated countries studied, India, Nigeria, and...
Women outshine men for GM promotions in PSU general insurance companies
Out of 16 vacancies of general mangers across five companies...
Fiscal deficit at 120 pc of annual target at October-end
The deficit widened mainly on account of poor revenue realisation. The lockdown imposed to curb spreading of coronavirus infections had significantly impacted business activities and in turn contributed to sluggish revenue realisation.
The fiscal deficit at the end of September 2020 was about 114.8 per cent of the annual budget estimate.
International passenger flights to remain suspended till December 31
However, these restrictions won’t apply to cargo operations and services approved by the DGCA.
The DGCA also added that select international flights on limited routes may be allowed by competent authorities on case to case basis.
Mamata announces health scheme for all in WB
The scheme, officially launched by Banerjee in December 2016 is a basic health cover for secondary and tertiary care up to Rs five lakh per annum per family.
India records 44,489 new coronavirus cases
The active cases comprise 4.88 per cent of the total caseload, the data stated.
The total number of people who have recuperated from the disease surged to 86,79,138, pushing the national recovery rate to 93.66 per cent, while the Covid-19 case fatality rate stands at 1.46 per cent.
Govt launches ‘Mission Covid Suraksha’ to help accelerate vaccine candidates
The mission envisages Covid-19 vaccine development with end-to-end focus from preclinical through clinical development and manufacturing and regulatory facilitation, the DBT said.
Earlier this month, the government had announced a package of Rs 900 crore for vaccines.
Phase-3 trial of Bharat Biotech’s Covaxin commences in AIIMS
Besides, Covaxin, four other vaccines are under different phases of clinical trial in India with the Serum Institute of India conducting phase-three trial of the Oxford-Astrazeneca Covid-19 vaccine while the indigenously developed vaccine by Zydus Cadila has completed phase-two clinical trial in the country.
Over 50,000 Ayushman Bharat Health and Wellness Centres operational across country
AstraZeneca faces more Covid-19 vaccine questions after manufacturing error
In a statement, Oxford said a difference in manufacturing processes led to later phases of the trials having a half-dose given instead of a full one. When it was apparent that a lower dose was used, it was discussed with regulators, and an agreement was reached to push ahead with the two regimens, the statement said.
The biggest threat to Covid-19 vaccination could be fake news and misinformation
“The coronavirus disease is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected,” the WHO said.
“At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine the global response and jeopardises measures to control the pandemic.”
Covid vaccine rush in China raises fears of booming black market
As developers from AstraZeneca Plc to Pfizer Inc. near the finish line for their coronavirus vaccines, nations are preparing for the challenge of rolling them out, with inevitable supply shortages fueling concerns about inequitable distribution and even the emergence of illegal markets. One place where vaccine delivery is already being road-tested is China, which has allowed local developers’ shots for emergency use since mid-year.